COVID-19 Saliva Screening Test Potential Market Report 2026

COVID-19 Saliva Screening Test Potential Market Overview

• COVID-19 Saliva Screening Test Potential market size has reached to $4.28 billion in 2025 • Expected to grow to $6.46 billion in 2030 at a compound annual growth rate (CAGR) of 8.4% • Growth Driver: The Role Of Increasing Healthcare Expenditure In Driving The Growth Of The COVID-19 Saliva Screening Test Market • Market Trend: Innovative Data Sharing Platforms Enhancing COVID-19 Saliva Screening And Public Health Preparedness • North America was the largest region in 2025.

What Is Covered Under COVID-19 Saliva Screening Test Potential Market?

The COVID-19 saliva screening test potential refers to the potential advantages and capabilities that saliva-based tests for detecting SARS-CoV-2, the virus that causes COVID-19, could offer compared to traditional methods such as nasopharyngeal or oropharyngeal swab tests. Their potential lies in improving testing accessibility, patient acceptance, cost-effectiveness, and safety while enabling new testing strategies and approaches to manage the COVID-19 pandemic better. The main locations of COVID-19 saliva screening test potential are travel stations, sports arenas, entertainment venues, corporate campus environments, universities and colleges, factories, and other locations. Travel stations are designated areas in transportation hubs where individuals can undergo COVID-19 saliva screening tests before embarking on journeys. The various technologies used are fluorescence-labeled antigen, rt-PCR, and CRISPR-Cas9 and various modes of testing include centralized testing and decentralized testing.

What Is The COVID-19 Saliva Screening Test Potential Market Growth Forecast?

The covid-19 saliva screening test potential market size is expected to see strong growth in the next few years. It will grow to $6.46 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to future pandemic preparedness strategies, growth of decentralized diagnostics, expansion of workplace testing, cost-effective mass screening demand, innovation in saliva-based technologies. Major trends in the forecast period include shift toward non-invasive testing methods, expansion of large-scale community screening, growing acceptance of self-collection testing, deployment in high-traffic public locations, integration with workplace safety programs.

Global COVID-19 Saliva Screening Test Potential Market Segmentation

1) By Location: Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments, Universities And Colleges, Factories, Other Locations 2) By Technology: Fluorescence-Labelled Antigen, RT-PCR, CRISPR-Cas9 3) By Mode Of Testing: Centralized Testing, Decentralized Testing Subsegments: 1) By Travel Stations: Airports, Train Stations, Bus Stations, Seaports 2) By Sports Arenas: Stadiums, Arenas, Event Halls 3) By Entertainment Venues: Theaters, Concert Halls, Amusement Parks, Nightclubs 4) By Corporate Campus Environments: Offices, Corporate Campuses, Business Parks 5) By Universities And Colleges: Higher Education Campuses, Research Institutions, Student Housing Areas 6) By Factories: Manufacturing Plants, Production Facilities, Industrial Sites 7) By Other Locations: Healthcare Facilities, Government Buildings, Public Transportation Hubs, Shopping Centers

What Is The Driver Of The COVID-19 Saliva Screening Test Potential Market?

The increasing healthcare expenditure is expected to propel the growth of the COVID-19 saliva screening test potential market going forward. Healthcare expenditure is the entire amount spent on healthcare-related goods and services, including prescription drugs, hospital stays, doctor visits, medical equipment, and public health campaigns. The healthcare expenditure is increasing due to several factors, such as minimally invasive surgeries, cutting-edge diagnostic tools, increase in research and development for new drugs, utilization of healthcare services, and specialty medications. The higher healthcare expenditure can provide the necessary resources and support to leverage the full potential of COVID-19 saliva screening tests, contributing to more effective pandemic management and better public health outcomes. For instance, in December 2024, according to the U.S. Centers for Medicare & Medicaid Services (CMS), a US-based federal health agency, national health-care spending rose by 7.5%, reaching US $4.9 trillion, compared to the previous year. Therefore, the increasing healthcare expenditure is driving the growth of the COVID-19 saliva screening test potential industry.

Key Players In The Global COVID-19 Saliva Screening Test Potential Market

Major companies operating in the covid-19 saliva screening test potential market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Danaher Corporation, University of North Carolina at Chapel Hill, Hologic Inc., Beaumont Health, PerkinElmer Inc., Quidel Corporation, University of Illinois at Urbana-Champaign, Cepheid, Seegene Inc., ARUP Laboratories, Vatic Health Limited, Ambry Genetics Corporation, LumiraDx Ltd., Yale School of Public Health, Gravity Diagnostics, Psomagen Inc., Fluidigm Corporation, Phosphorus Diagnostics LLC, DxTerity Diagnostics Inc., University of Notre Dame, MOgene

Global COVID-19 Saliva Screening Test Potential Market Trends and Insights

Major companies operating in the COVID-19 saliva screening test potential market are focused on developing innovative technologies such as data-sharing platforms to enhance real-time communication and collaboration among healthcare providers, laboratories, and public health authorities, ultimately improving the efficiency and accuracy of testing, tracking, and response efforts during the pandemic. Data-sharing platforms are digital systems that enable the secure exchange of data among various stakeholders, such as healthcare providers, researchers, and organizations. They facilitate collaboration and information access to improve decision-making, efficiency, and outcomes across sectors. For instance, in May 2024, Mount Sinai Health System, a US-based healthcare network, launched the Center for Healthcare Readiness. The Center focuses on improving strategies for public health emergency response, ensuring that healthcare systems can effectively handle large-scale crises such as pandemics or natural disasters. It aims to enhance the capacity of the Mount Sinai Health System and collaborate with local, regional, and federal partners to develop comprehensive preparedness plans.

What Are Latest Mergers And Acquisitions In The COVID-19 Saliva Screening Test Potential Market?

In July 2024, Hologic, Inc., a US-based health technology company, acquired Endomagnetics Ltd. for an undisclosed amount. With this acquisition, Hologic, Inc. aims to enhance its portfolio of innovative healthcare solutions and expand its market presence in the women's health sector. Endomagnetics Ltd. is a UK-based medical technology company that manufactures medical devices that help detect cancerous lymph nodes during surgery.

Regional Outlook

North America was the largest region in the COVID-19 saliva screening test potential market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the COVID-19 Saliva Screening Test Potential Market?

The COVID-19 saliva screening test potential market consist revenues earned by entities by providing services such as sample collection services, laboratory testing services, diagnostic reporting services, and screening and monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The COVID-19 saliva screening test potential market also consists of sales of saliva collection kits, rapid saliva testing kits, laboratory testing supplies, and automated sample processing systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the COVID-19 Saliva Screening Test Potential Market Report 2026?

The covid-19 saliva screening test potential market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the covid-19 saliva screening test potential industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.